Skip to main content

News

By Healthcare Finance Staff | 01:32 pm | July 10, 2014
As Affordable Care Act exchanges bring health plans to previously uninsured Americans, there are also market segment transitions that could prove favorable for risk pools.
By Healthcare Finance Staff | 11:30 am | July 10, 2014
Trying to help transition the American healthcare system beyond fee-for-service, Blue Cross and Blue Shield companies are starting to reach new reimbursement milestones.
By Anthony Brino | 10:13 am | July 10, 2014
Medicare regulators are updating hospital outpatient and ambulatory surgery center payments for next year, and also outlining a potential remedy to private Medicare overpayments.
By Healthcare Finance Staff | 12:46 pm | July 09, 2014
UnitedHealthcare's bid to change financial incentives for oncologists has led to some promising, though somewhat mixed results.
By Eric Whitney | 12:06 pm | July 09, 2014
A new study says there's no need to worry about hospitals using their new electronic medical records to generate bigger bills and boost their income, but the study may not be checking the right data.
By Healthcare Finance Staff | 11:15 am | July 09, 2014
Joining its peers in touting accountable care, Cigna has met a fairly ambitious goal set two years ago, but more time is needed to test the strategy's sustainability.
By Healthcare Finance Staff | 09:34 am | July 09, 2014
One regional insurer is using a new approach in provider network management, as it aims to tackle a laborious administrative process.
By Healthcare Finance Staff | 08:47 am | July 09, 2014
One of the country's largest health insurers is being accused of having misleading information on doctor and hospital network participation for EPO and PPO plans sold in the state exchange.
By Anthony Brino | 05:45 am | July 09, 2014
The growth of total U.S. medical costs is slowing down, but one segment is expanding fast: prescription drug costs.
By Healthcare Finance Staff | 10:24 am | July 08, 2014
With spending on diagnostics alone for cardiovascular disease likely to be a major challenge for insurers amid the baby boom wave, Aetna is turning to an emerging option as part of a strategy to avoid invasive tests and treatments.